Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P204 Reducing Antigen Exposure in Pigeon Breeders. Wearing a Mask Is a Sign of Disease

Thorax

Pulmonary

Respiratory Medicine

2013

English

Searching for ROS1 Rearrangements in Lung Cancer by Fluorescent in Situ Hybridization: The Importance of Probe Design

Journal of Thoracic Oncology

English

MTE24.02 Small Lung Tumours: High Risk Lesions and Contraindications to Stereotactic Ablative Body Radiotherapy (SABR)

Journal of Thoracic Oncology

English

PC04.02 Optimal Sequencing of EGFR TKI Therapy - 3rd Generation First

Journal of Thoracic Oncology

English

P2.09-31 Cisplatinum Suppressed Metastasis of NSCLC by Inhibiting Macrophage M2-Like Polarization

Journal of Thoracic Oncology

English

P3.01-18 Comparison of PD-L1 Immunohistochemical Assays and Clinical Response to Anti PD-1 Checkpoint Inhibitors in Patients With Lung Cancer

Journal of Thoracic Oncology

English

P3.01-37 Phase II Study of Amrubicin Plus Erlotinib in Previously Treated, Advanced Non-Small Cell Lung Cancer Patients With Wild-Type EGFR: TORG 1320

Journal of Thoracic Oncology

English

MA21.03 Heterogeneity in MET Copy Number and Intratumoural Subsets in Pleomorphic Lung Carcinoma: Implications for MET Directed Therapy in NSCLC

Journal of Thoracic Oncology

English

P2.11-27 a Rapid Access Lung Cancer Clinic Reduces Variation in Lung Cancer Diagnostic and Treatment Services.

Journal of Thoracic Oncology

English

P3.01-01 Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P204 Reducing Antigen Exposure in Pigeon Breeders. Wearing a Mask Is a Sign of Disease

Searching for ROS1 Rearrangements in Lung Cancer by Fluorescent in Situ Hybridization: The Importance of Probe Design

MTE24.02 Small Lung Tumours: High Risk Lesions and Contraindications to Stereotactic Ablative Body Radiotherapy (SABR)

PC04.02 Optimal Sequencing of EGFR TKI Therapy - 3rd Generation First

P2.09-31 Cisplatinum Suppressed Metastasis of NSCLC by Inhibiting Macrophage M2-Like Polarization

P3.01-18 Comparison of PD-L1 Immunohistochemical Assays and Clinical Response to Anti PD-1 Checkpoint Inhibitors in Patients With Lung Cancer

P3.01-37 Phase II Study of Amrubicin Plus Erlotinib in Previously Treated, Advanced Non-Small Cell Lung Cancer Patients With Wild-Type EGFR: TORG 1320

MA21.03 Heterogeneity in MET Copy Number and Intratumoural Subsets in Pleomorphic Lung Carcinoma: Implications for MET Directed Therapy in NSCLC

P2.11-27 a Rapid Access Lung Cancer Clinic Reduces Variation in Lung Cancer Diagnostic and Treatment Services.

P3.01-01 Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients